Drug Makers Raising Prices On Prescription Medicines Because They Can

Drug Makers Raising Prices On Prescription Medicines Because They Can

Imatinib, a cancer drug sold under the name Gleevec by Novartis, is a life-saving and life-prolonging medication. The question for many patients, however, is: how much are they willing to pay to prolong their lives, and how much profit a company can make from one medication before it becomes immoral. [More]